カテゴリ： 世界, 医療/バイオ, QYResearch

ゲノム＆プロテオミクスツールの世界市場2023年：ゲノミクス、プロテオミクス

■ 英語タイトル：Global Genomic and Proteomic Tool Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7472）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7472
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ゲノム＆プロテオミクスツールの世界市場2023年：ゲノミクス、プロテオミクス]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はゲノム＆プロテオミクスツールのグローバル市場について調査・分析し、世界のゲノム＆プロテオミクスツール市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ゲノミクス、プロテオミクス）、用途別セグメント分析（研究所＆研究所、創薬、バイオインフォマティクス、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、3billion, Inc.、Bio-Rad Laboratories, Inc.、Lucigen Corp.、Macrogen, Inc.、Abbott、Thermal Fisher Scientific, Inc.、Bio-Synthesis, Inc.、GE Healthcare、QIAGEN NV、Novogene Corp.、Waters Corp.、OriGene Technologies、Takara Bio, Inc.、Vela Diagnosticsなどが含まれています。ゲノム＆プロテオミクスツールのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ゲノム＆プロテオミクスツール市場規模を算出する際に考慮しました。

・ゲノム＆プロテオミクスツール市場の概要
- ゲノム＆プロテオミクスツールの種類別セグメント
- 世界のゲノム＆プロテオミクスツール市場規模：タイプ別分析（ゲノミクス、プロテオミクス）
- ゲノム＆プロテオミクスツールの用途別セグメント
- 世界のゲノム＆プロテオミクスツール市場規模：用途別分析（研究所＆研究所、創薬、バイオインフォマティクス、その他）
- 世界のゲノム＆プロテオミクスツール市場規模予測（2018年-2029年）

・ゲノム＆プロテオミクスツール市場の成長トレンド
- ゲノム＆プロテオミクスツールの地域別市場規模（2018年-2029年）
- ゲノム＆プロテオミクスツール市場ダイナミクス
- ゲノム＆プロテオミクスツールの業界動向
- ゲノム＆プロテオミクスツール市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：ゲノミクス、プロテオミクス
- 世界のゲノム＆プロテオミクスツールのタイプ別市場規模（2018年-2023年）
- 世界のゲノム＆プロテオミクスツールのタイプ別市場規模（2024年-2029年）

・用途別セグメント：研究所＆研究所、創薬、バイオインフォマティクス、その他
- 世界のゲノム＆プロテオミクスツールの用途別市場規模（2018年-2023年）
- 世界のゲノム＆プロテオミクスツールの用途別市場規模（2024年-2029年）

・ゲノム＆プロテオミクスツールの地域別市場規模
- 北米のゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- 米国のゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- ヨーロッパのゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- アジア太平洋のゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- 中国のゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- 日本のゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- 韓国のゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- インドのゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- オーストラリアのゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- 中南米のゲノム＆プロテオミクスツール市場規模（2018年-2029年）
- 中東・アフリカのゲノム＆プロテオミクスツール市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
3billion, Inc.、Bio-Rad Laboratories, Inc.、Lucigen Corp.、Macrogen, Inc.、Abbott、Thermal Fisher Scientific, Inc.、Bio-Synthesis, Inc.、GE Healthcare、QIAGEN NV、Novogene Corp.、Waters Corp.、OriGene Technologies、Takara Bio, Inc.、Vela Diagnostics

・アナリストの観点/結論

・調査手法と情報源

Smart food logistics provider helps FMCG industries to maintain the quality of foods, such as fruits and vegetables, so that it does not spoil. Smart food logistics companies use wireless temperature sensors that help preserve frozen foods and provide multi-zone monitoring in refrigerated trucks and trailers.
Highlights
The global Genomic and Proteomic Tool market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Genomic and Proteomic Tool is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Genomic and Proteomic Tool is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Genomic and Proteomic Tool in Research Labs and Institutes is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Genomic and Proteomic Tool include 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare and QIAGEN NV, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genomic and Proteomic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic and Proteomic Tool.
The Genomic and Proteomic Tool market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genomic and Proteomic Tool market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomic and Proteomic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
3billion, Inc.
Bio-Rad Laboratories, Inc.
Lucigen Corp.
Macrogen, Inc.
Abbott
Thermal Fisher Scientific, Inc.
Bio-Synthesis, Inc.
GE Healthcare
QIAGEN NV
Novogene Corp.
Waters Corp.
OriGene Technologies
Takara Bio, Inc.
Vela Diagnostics
Segment by Type
Genomics
Proteomics
Segment by Application
Research Labs and Institutes
Drug Discovery
Bioinformatics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic and Proteomic Tool companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic and Proteomic Tool Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Genomics
1.2.3 Proteomics
1.3 Market by Application
1.3.1 Global Genomic and Proteomic Tool Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Research Labs and Institutes
1.3.3 Drug Discovery
1.3.4 Bioinformatics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic and Proteomic Tool Market Perspective (2018-2029)
2.2 Genomic and Proteomic Tool Growth Trends by Region
2.2.1 Global Genomic and Proteomic Tool Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genomic and Proteomic Tool Historic Market Size by Region (2018-2023)
2.2.3 Genomic and Proteomic Tool Forecasted Market Size by Region (2024-2029)
2.3 Genomic and Proteomic Tool Market Dynamics
2.3.1 Genomic and Proteomic Tool Industry Trends
2.3.2 Genomic and Proteomic Tool Market Drivers
2.3.3 Genomic and Proteomic Tool Market Challenges
2.3.4 Genomic and Proteomic Tool Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic and Proteomic Tool Players by Revenue
3.1.1 Global Top Genomic and Proteomic Tool Players by Revenue (2018-2023)
3.1.2 Global Genomic and Proteomic Tool Revenue Market Share by Players (2018-2023)
3.2 Global Genomic and Proteomic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomic and Proteomic Tool Revenue
3.4 Global Genomic and Proteomic Tool Market Concentration Ratio
3.4.1 Global Genomic and Proteomic Tool Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic and Proteomic Tool Revenue in 2022
3.5 Genomic and Proteomic Tool Key Players Head office and Area Served
3.6 Key Players Genomic and Proteomic Tool Product Solution and Service
3.7 Date of Enter into Genomic and Proteomic Tool Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic and Proteomic Tool Breakdown Data by Type
4.1 Global Genomic and Proteomic Tool Historic Market Size by Type (2018-2023)
4.2 Global Genomic and Proteomic Tool Forecasted Market Size by Type (2024-2029)
5 Genomic and Proteomic Tool Breakdown Data by Application
5.1 Global Genomic and Proteomic Tool Historic Market Size by Application (2018-2023)
5.2 Global Genomic and Proteomic Tool Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genomic and Proteomic Tool Market Size (2018-2029)
6.2 North America Genomic and Proteomic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genomic and Proteomic Tool Market Size by Country (2018-2023)
6.4 North America Genomic and Proteomic Tool Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomic and Proteomic Tool Market Size (2018-2029)
7.2 Europe Genomic and Proteomic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genomic and Proteomic Tool Market Size by Country (2018-2023)
7.4 Europe Genomic and Proteomic Tool Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic and Proteomic Tool Market Size (2018-2029)
8.2 Asia-Pacific Genomic and Proteomic Tool Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2018-2023)
8.4 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomic and Proteomic Tool Market Size (2018-2029)
9.2 Latin America Genomic and Proteomic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genomic and Proteomic Tool Market Size by Country (2018-2023)
9.4 Latin America Genomic and Proteomic Tool Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic and Proteomic Tool Market Size (2018-2029)
10.2 Middle East & Africa Genomic and Proteomic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2018-2023)
10.4 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3billion, Inc.
11.1.1 3billion, Inc. Company Detail
11.1.2 3billion, Inc. Business Overview
11.1.3 3billion, Inc. Genomic and Proteomic Tool Introduction
11.1.4 3billion, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.1.5 3billion, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Detail
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Lucigen Corp.
11.3.1 Lucigen Corp. Company Detail
11.3.2 Lucigen Corp. Business Overview
11.3.3 Lucigen Corp. Genomic and Proteomic Tool Introduction
11.3.4 Lucigen Corp. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.3.5 Lucigen Corp. Recent Development
11.4 Macrogen, Inc.
11.4.1 Macrogen, Inc. Company Detail
11.4.2 Macrogen, Inc. Business Overview
11.4.3 Macrogen, Inc. Genomic and Proteomic Tool Introduction
11.4.4 Macrogen, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.4.5 Macrogen, Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Genomic and Proteomic Tool Introduction
11.5.4 Abbott Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.5.5 Abbott Recent Development
11.6 Thermal Fisher Scientific, Inc.
11.6.1 Thermal Fisher Scientific, Inc. Company Detail
11.6.2 Thermal Fisher Scientific, Inc. Business Overview
11.6.3 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Introduction
11.6.4 Thermal Fisher Scientific, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.6.5 Thermal Fisher Scientific, Inc. Recent Development
11.7 Bio-Synthesis, Inc.
11.7.1 Bio-Synthesis, Inc. Company Detail
11.7.2 Bio-Synthesis, Inc. Business Overview
11.7.3 Bio-Synthesis, Inc. Genomic and Proteomic Tool Introduction
11.7.4 Bio-Synthesis, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.7.5 Bio-Synthesis, Inc. Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Detail
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Genomic and Proteomic Tool Introduction
11.8.4 GE Healthcare Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.8.5 GE Healthcare Recent Development
11.9 QIAGEN NV
11.9.1 QIAGEN NV Company Detail
11.9.2 QIAGEN NV Business Overview
11.9.3 QIAGEN NV Genomic and Proteomic Tool Introduction
11.9.4 QIAGEN NV Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.9.5 QIAGEN NV Recent Development
11.10 Novogene Corp.
11.10.1 Novogene Corp. Company Detail
11.10.2 Novogene Corp. Business Overview
11.10.3 Novogene Corp. Genomic and Proteomic Tool Introduction
11.10.4 Novogene Corp. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.10.5 Novogene Corp. Recent Development
11.11 Waters Corp.
11.11.1 Waters Corp. Company Detail
11.11.2 Waters Corp. Business Overview
11.11.3 Waters Corp. Genomic and Proteomic Tool Introduction
11.11.4 Waters Corp. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.11.5 Waters Corp. Recent Development
11.12 OriGene Technologies
11.12.1 OriGene Technologies Company Detail
11.12.2 OriGene Technologies Business Overview
11.12.3 OriGene Technologies Genomic and Proteomic Tool Introduction
11.12.4 OriGene Technologies Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.12.5 OriGene Technologies Recent Development
11.13 Takara Bio, Inc.
11.13.1 Takara Bio, Inc. Company Detail
11.13.2 Takara Bio, Inc. Business Overview
11.13.3 Takara Bio, Inc. Genomic and Proteomic Tool Introduction
11.13.4 Takara Bio, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.13.5 Takara Bio, Inc. Recent Development
11.14 Vela Diagnostics
11.14.1 Vela Diagnostics Company Detail
11.14.2 Vela Diagnostics Business Overview
11.14.3 Vela Diagnostics Genomic and Proteomic Tool Introduction
11.14.4 Vela Diagnostics Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.14.5 Vela Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Genomic and Proteomic Tool Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Genomics
Table 3. Key Players of Proteomics
Table 4. Global Genomic and Proteomic Tool Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Genomic and Proteomic Tool Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Genomic and Proteomic Tool Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Genomic and Proteomic Tool Market Share by Region (2018-2023)
Table 8. Global Genomic and Proteomic Tool Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Genomic and Proteomic Tool Market Share by Region (2024-2029)
Table 10. Genomic and Proteomic Tool Market Trends
Table 11. Genomic and Proteomic Tool Market Drivers
Table 12. Genomic and Proteomic Tool Market Challenges
Table 13. Genomic and Proteomic Tool Market Restraints
Table 14. Global Genomic and Proteomic Tool Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Genomic and Proteomic Tool Market Share by Players (2018-2023)
Table 16. Global Top Genomic and Proteomic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2022)
Table 17. Ranking of Global Top Genomic and Proteomic Tool Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Genomic and Proteomic Tool Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Genomic and Proteomic Tool Product Solution and Service
Table 21. Date of Enter into Genomic and Proteomic Tool Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Genomic and Proteomic Tool Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Genomic and Proteomic Tool Revenue Market Share by Type (2018-2023)
Table 25. Global Genomic and Proteomic Tool Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Genomic and Proteomic Tool Revenue Market Share by Type (2024-2029)
Table 27. Global Genomic and Proteomic Tool Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Genomic and Proteomic Tool Revenue Market Share by Application (2018-2023)
Table 29. Global Genomic and Proteomic Tool Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Genomic and Proteomic Tool Revenue Market Share by Application (2024-2029)
Table 31. North America Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Genomic and Proteomic Tool Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Genomic and Proteomic Tool Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Genomic and Proteomic Tool Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Genomic and Proteomic Tool Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Genomic and Proteomic Tool Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Genomic and Proteomic Tool Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Genomic and Proteomic Tool Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2024-2029) & (US$ Million)
Table 46. 3billion, Inc. Company Detail
Table 47. 3billion, Inc. Business Overview
Table 48. 3billion, Inc. Genomic and Proteomic Tool Product
Table 49. 3billion, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 50. 3billion, Inc. Recent Development
Table 51. Bio-Rad Laboratories, Inc. Company Detail
Table 52. Bio-Rad Laboratories, Inc. Business Overview
Table 53. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Product
Table 54. Bio-Rad Laboratories, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 55. Bio-Rad Laboratories, Inc. Recent Development
Table 56. Lucigen Corp. Company Detail
Table 57. Lucigen Corp. Business Overview
Table 58. Lucigen Corp. Genomic and Proteomic Tool Product
Table 59. Lucigen Corp. Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 60. Lucigen Corp. Recent Development
Table 61. Macrogen, Inc. Company Detail
Table 62. Macrogen, Inc. Business Overview
Table 63. Macrogen, Inc. Genomic and Proteomic Tool Product
Table 64. Macrogen, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 65. Macrogen, Inc. Recent Development
Table 66. Abbott Company Detail
Table 67. Abbott Business Overview
Table 68. Abbott Genomic and Proteomic Tool Product
Table 69. Abbott Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Thermal Fisher Scientific, Inc. Company Detail
Table 72. Thermal Fisher Scientific, Inc. Business Overview
Table 73. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Product
Table 74. Thermal Fisher Scientific, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 75. Thermal Fisher Scientific, Inc. Recent Development
Table 76. Bio-Synthesis, Inc. Company Detail
Table 77. Bio-Synthesis, Inc. Business Overview
Table 78. Bio-Synthesis, Inc. Genomic and Proteomic Tool Product
Table 79. Bio-Synthesis, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 80. Bio-Synthesis, Inc. Recent Development
Table 81. GE Healthcare Company Detail
Table 82. GE Healthcare Business Overview
Table 83. GE Healthcare Genomic and Proteomic Tool Product
Table 84. GE Healthcare Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 85. GE Healthcare Recent Development
Table 86. QIAGEN NV Company Detail
Table 87. QIAGEN NV Business Overview
Table 88. QIAGEN NV Genomic and Proteomic Tool Product
Table 89. QIAGEN NV Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 90. QIAGEN NV Recent Development
Table 91. Novogene Corp. Company Detail
Table 92. Novogene Corp. Business Overview
Table 93. Novogene Corp. Genomic and Proteomic Tool Product
Table 94. Novogene Corp. Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 95. Novogene Corp. Recent Development
Table 96. Waters Corp. Company Detail
Table 97. Waters Corp. Business Overview
Table 98. Waters Corp. Genomic and Proteomic Tool Product
Table 99. Waters Corp. Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 100. Waters Corp. Recent Development
Table 101. OriGene Technologies Company Detail
Table 102. OriGene Technologies Business Overview
Table 103. OriGene Technologies Genomic and Proteomic Tool Product
Table 104. OriGene Technologies Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 105. OriGene Technologies Recent Development
Table 106. Takara Bio, Inc. Company Detail
Table 107. Takara Bio, Inc. Business Overview
Table 108. Takara Bio, Inc. Genomic and Proteomic Tool Product
Table 109. Takara Bio, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 110. Takara Bio, Inc. Recent Development
Table 111. Vela Diagnostics Company Detail
Table 112. Vela Diagnostics Business Overview
Table 113. Vela Diagnostics Genomic and Proteomic Tool Product
Table 114. Vela Diagnostics Revenue in Genomic and Proteomic Tool Business (2018-2023) & (US$ Million)
Table 115. Vela Diagnostics Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomic and Proteomic Tool Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Genomic and Proteomic Tool Market Share by Type: 2022 VS 2029
Figure 3. Genomics Features
Figure 4. Proteomics Features
Figure 5. Global Genomic and Proteomic Tool Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Genomic and Proteomic Tool Market Share by Application: 2022 VS 2029
Figure 7. Research Labs and Institutes Case Studies
Figure 8. Drug Discovery Case Studies
Figure 9. Bioinformatics Case Studies
Figure 10. Others Case Studies
Figure 11. Genomic and Proteomic Tool Report Years Considered
Figure 12. Global Genomic and Proteomic Tool Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Genomic and Proteomic Tool Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Genomic and Proteomic Tool Market Share by Region: 2022 VS 2029
Figure 15. Global Genomic and Proteomic Tool Market Share by Players in 2022
Figure 16. Global Top Genomic and Proteomic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Genomic and Proteomic Tool Revenue in 2022
Figure 18. North America Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Genomic and Proteomic Tool Market Share by Country (2018-2029)
Figure 20. United States Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Genomic and Proteomic Tool Market Share by Country (2018-2029)
Figure 24. Germany Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Genomic and Proteomic Tool Market Share by Region (2018-2029)
Figure 32. China Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Genomic and Proteomic Tool Market Share by Country (2018-2029)
Figure 40. Mexico Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Genomic and Proteomic Tool Market Share by Country (2018-2029)
Figure 44. Turkey Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Genomic and Proteomic Tool Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. 3billion, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 47. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 48. Lucigen Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 49. Macrogen, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 50. Abbott Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 51. Thermal Fisher Scientific, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 52. Bio-Synthesis, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 53. GE Healthcare Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 54. QIAGEN NV Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 55. Novogene Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 56. Waters Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 57. OriGene Technologies Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 58. Takara Bio, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 59. Vela Diagnostics Revenue Growth Rate in Genomic and Proteomic Tool Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ゲノム及びプロテオミクスツールのグローバル市場展望 2023年-2029年：ゲノミクス、プロテオミクス
  • RFコネクタツールの世界市場2023年：はんだ付けツール、組立ツール、誘電体リセスツール、引き抜きツール、その他
  • 航空宇宙工作機械の世界市場2023年：3軸、4軸、5軸、その他
  • ケーブルツールの世界市場2023年：切削工具、剥離工具、その他
  • 脳震盪の世界市場2023年：治療、診断
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7472 )"ゲノム＆プロテオミクスツールの世界市場2023年：ゲノミクス、プロテオミクス" (英文：Global Genomic and Proteomic Tool Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。